Abstract: A glass article includes a first surface, a second surface opposed to the first surface, a first compressive region extending from the first surface to a first compression depth, a second compressive region extending from the second surface to a second compression depth and a tensile region between the first compression depth and the second compression depth. A stress profile of the first compressive region includes a first segment located between the first surface and a first transition point and a second segment located between the first transition point and the first compression depth. A depth from the first surface to the first transition point ranges from 6.1 ?m to 8.1 ?m. A compressive stress at the first transition point ranges from 207 MPa to 254 MPa. A stress-depth ratio of the first transition point ranges from 28 MPa/?m to 35 MPa/?m.

Abstract: A glass article includes lithium aluminosilicate, includes a first surface, a second surface opposed to the first surface, a first compressive region extending from the first surface to a first compression depth, a second compressive region extending from the second surface to a second compression depth, and, a tensile region disposed between the first compression depth and the second compression depth, where a stress profile of the first compressive region has a first local minimum point at which the stress profile is convex downward and a first local maximum point at which the stress profile is convex upward, where a depth of the first local maximum point is greater than a depth of the first local minimum point, and where a stress of the first local maximum point is greater than a compressive stress of the first local minimum point.

Abstract: A glass article includes a first surface; a second surface opposed to the first surface; a side surface connecting the first surface to the second surface; a first surface compressive region extending from the first surface to a first depth; a second surface compressive region extending from the second surface to a second depth; and a side compressive region extending from the side surface to a third depth, where the first surface and the side surface are non-tin surfaces, the second surface is a tin surface, and a maximum compressive stress of the second surface compressive region is greater than a maximum compressive stress of the first surface compressive region.

Abstract: The present invention relates to a Pde6b-deficient animal model of retinal degeneration produced by engineered endonucleases, and a method for producing the same. In the animal model of retinal degeneration according to the present invention, only a specific target gene can be removed using engineered endonucleases, so that mutagenesis can be stably achieved. In addition, it is possible to produce a congenital animal model through genetic manipulation at the embryonic stage rather than through acquired factors, which allows for production of an animal model that uniformly exhibits symptoms of the disease in question without being influenced by other factors.

Abstract: The present invention relates to a Pde6b-deficient animal model of retinal degeneration produced by engineered endonucleases, and a method for producing the same. In the animal model of retinal degeneration according to the present invention, only a specific target gene can be removed using engineered endonucleases, so that mutagenesis can be stably achieved. In addition, it is possible to produce a congenital animal model through genetic manipulation at the embryonic stage rather than through acquired factors, which allows for production of an animal model that uniformly exhibits symptoms of the disease in question without being influenced by other factors.

Abstract: Provided herein are a pharmaceutical composition for the prevention and treatment of cancer, including, as an active ingredient, E124 protein or a fragment thereof, or an expression vector including a nucleotide sequence encoding the E124 protein or the fragment thereof, and a method of screening a cancer therapeutic agent candidate.

Abstract: Disclosed is a composition for treating or preventing a viral infection or associated disease comprising a Jab1 protein, a nucleic acid having a nucleotide sequence coding for a Jab1 protein or a recombinant virus expressing a Jab1 protein.

Abstract: Disclosed is a composition for treating or preventing a viral infection or associated disease comprising a Jab1 protein, a nucleic acid having a nucleotide sequence coding for a Jab1 protein or a recombinant virus expressing a Jab1 protein.

Abstract: A human detection method and apparatus are provided. In the method, a person is detected from an image provided by a digital video camera. The method includes (a) initializing parameters used for a user detection; (b) determining a current mode; (c) when it is determined that the current mode is the face detection mode, performing a face detection on each of a plurality of image frames, and when a face is not detected even after a predetermined number of face detection trials, selecting a motion detection mode and going back to step (b); and (d) when it is determined that the current mode is the motion detection mode, performing a motion detection on a predetermined number of image frames at a time, and when at least a predetermined number of motion detections are performed successfully within a predetermined period of time, going back to step (a).

Abstract: A human detection method and apparatus are provided. In the method, a person is detected from an image provided by a digital video camera. The method includes (a) initializing parameters used for a user detection; (b) determining a current mode; (c) when it is determined that the current mode is the face detection mode, performing a face detection on each of a plurality of image frames, and when a face is not detected even after a predetermined number of face detection trials, selecting a motion detection mode and going back to step (b); and (d) when it is determined that the current mode is the motion detection mode, performing a motion detection on a predetermined number of image frames at a time, and when at least a predetermined number of motion detections are performed successfully within a predetermined period of time, going back to step (a).

Abstract: Disclosed is a composition for treating or preventing a viral infection or associated disease comprising a Jab1 protein, a nucleic acid having a nucleotide sequence coding for a Jab1 protein or a recombinant virus expressing a jab1 protein.

Abstract: A human detection method and apparatus are provided. In the method, a person is detected from an image provided by a digital video camera. The method includes (a) initializing parameters used for a user detection; (b) determining a current mode; (c) when it is determined that the current mode is the face detection mode, performing a face detection on each of a plurality of image frames, and when a face is not detected even after a predetermined number of face detection trials, selecting a motion detection mode and going back to step (b); and (d) when it is determined that the current mode is the motion detection mode, performing a motion detection on a predetermined number of image frames at a time, and when at least a predetermined number of motion detections are performed successfully within a predetermined period of time, going back to step (a).

Abstract: A human detection method and apparatus are provided. In the method, a person is detected from an image provided by a digital video camera. The method includes (a) initializing parameters used for a user detection; (b) determining a current mode; (c) when it is determined that the current mode is the face detection mode, performing a face detection on each of a plurality of image frames, and when a face is not detected even after a predetermined number of face detection trials, selecting a motion detection mode and going back to step (b); and (d) when it is determined that the current mode is the motion detection mode, performing a motion detection on a predetermined number of image frames at a time, and when at least a predetermined number of motion detections are performed successfully within a predetermined period of time, going back to step (a).